1.
Indian J Pediatr
;
2009 May; 76(5): 531-536
Article
in English
| IMSEAR
| ID: sea-142201
ABSTRACT
In recent years there has been a growing interest towards pediatric movement disorders (PMD). The data derived from the synthesis of clinical observation, neuroimaging, biochemical and, molecular genetics studies have allowed for the identification of a significant number of pediatric diseases featuring movement disorders. The purpose of this review is to outline an approach to the advances in management of dystonia, neurotransmitter disorders, tics, and paroxysmal dyskinetic syndromes starting in children younger than 18 yr of age.
Subject(s)
Age Distribution , Age of Onset , Baclofen/therapeutic use , Benzodiazepines/therapeutic use , Child , Child, Preschool , Cholinergic Antagonists/therapeutic use , Dopamine Agents/therapeutic use , Drug Therapy, Combination , Dyskinesias/diagnosis , Dyskinesias/drug therapy , Dyskinesias/epidemiology , Early Diagnosis , Electromyography , Female , Humans , Incidence , Infant , Levodopa/therapeutic use , Male , Movement Disorders/diagnosis , Movement Disorders/drug therapy , Movement Disorders/epidemiology , Physical Examination , Prognosis , Risk Assessment , Severity of Illness Index , Sex Distribution , Spain , Treatment Outcome
2.
Buenos Aires; Panamericana; 2 ed; 1997. 945 p.
Monography
in Spanish
| LILACS
| ID: lil-598833